Get Full access to Top 1000 data, subscribe from only €29

UCB

Add to comparison

UCB is a global biopharma focused on severe diseases in two therapeutic areas: central nervous system and immunology operations. The company is listed on the Euronext Brussels Stock Exchange and has its headquarters in Brussels, Belgium. It employs more than 8,500 people in more than 40 countries.

Financial Data

31st Dec 17 Source: CRO
- €163 million turnover
- €12.2 million profit
- 1 employees
- Auditor: PwC
- Audit Fees: Purchase access »
- Non-Audit Fees: Purchase access »
- Tax On Profit: Purchase access »
31st Dec 16 Source: CRO
- €167.1 million turnover
- -€10.4 million profit
- 44 employees
- Auditor: PwC
- Audit Fees: Purchase access »
- Non-Audit Fees: Purchase access »
- Tax On Profit: Purchase access »
9 more years available »